<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotechnology Archives - Focal Point</title>
	<atom:link href="https://focalpointresearch.net/tag/biotechnology/feed/" rel="self" type="application/rss+xml" />
	<link>https://focalpointresearch.net/tag/biotechnology/</link>
	<description>Scientific, Regulatory and New Product Consultants</description>
	<lastBuildDate>Wed, 03 Jun 2020 14:40:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://focalpointresearch.net/wp-content/uploads/2021/11/cropped-focal_point_chart_03-32x32.jpg</url>
	<title>Biotechnology Archives - Focal Point</title>
	<link>https://focalpointresearch.net/tag/biotechnology/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">126679100</site>	<item>
		<title>COVID-19 Impacts on Biomedical Technology Industry</title>
		<link>https://focalpointresearch.net/medical-devices/covid-19-impacts-on-biomedical-technology-industry/</link>
		
		<dc:creator><![CDATA[Jenn Porter]]></dc:creator>
		<pubDate>Wed, 03 Jun 2020 14:40:41 +0000</pubDate>
				<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Medical Devices]]></category>
		<category><![CDATA[Research/Science/Technology]]></category>
		<category><![CDATA[Biomedical Technology]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Medical Device]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://www.focalpointresearch.net/?p=4851</guid>

					<description><![CDATA[<p>We have touched on many subjects regarding the COVID-19 pandemic, such as cosmetics, sanitization products, and updates to international regulations. However, there is one topic we have yet to discuss that has experienced a great impact during this difficult time, the biomedical technology field. The industry is usually recession-proof, but with social distancing measures, the [&#8230;]</p>
<p>The post <a href="https://focalpointresearch.net/medical-devices/covid-19-impacts-on-biomedical-technology-industry/">COVID-19 Impacts on Biomedical Technology Industry</a> appeared first on <a href="https://focalpointresearch.net">Focal Point</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>We have touched on many subjects regarding the COVID-19 pandemic, such as cosmetics, sanitization products, and updates to international regulations. However, there is one topic we have yet to discuss that has experienced a great impact during this difficult time, the biomedical technology field. The industry is usually recession-proof, but with social distancing measures, the industry has experienced some extreme setbacks.</p>



<p>The&nbsp;<a href="https://www.medtechdive.com/news/roundup-q1-medtech-reports-give-glimpse-into-coronavirus-era-gains-and-los/577455/">decline in the biomedical technology</a>&nbsp;industry was seen in the last weeks of March due to an overall decline in sales, procedures, and testing. As well, many hospitals restricted their surgeries to only necessary surgeries to preserve resources and staff. This&nbsp;<a href="https://www.medtechdive.com/news/surgeries-canceled-amid-coronavirus-contribute-to-50b-in-monthly-hospital/577476/">resulted</a>&nbsp;in great losses for hospitals and suppliers. However, the losses for hospitals continued through the cost of increasing PPE, reconfiguring spaces, new medical equipment, and the need for increased labor. Although some hospitals have started to allow elective surgeries to begin, such as hospitals in China, the surgery rate has not returned to its normal amount. It has been&nbsp;<a href="https://www.medtechdive.com/news/bd-says-surgery-revenues-fell-as-much-as-70-in-april/577549/">theorized</a>&nbsp;that this is from consumer hesitation and concern of safety. Therefore, although the decline is lessening, it may still be a while until the biomedical technology industry and hospitals return to normal.&nbsp;</p>



<p>With that being said, certain biomedical technology companies have actually experienced a dramatic increase in sales in certain departments. Companies that were already producing products that could aid in the coronavirus pandemic, such as assistive breathing and intensive care devices, have experienced an increase in profit caused by the high demand.&nbsp;&nbsp;For example,&nbsp;<a href="https://www.medtechdive.com/news/coronavirus-surge-in-critical-care-sales-helps-hillrom-beat-q2-guidance/577185/">Hillrom</a>, a producer of non-invasive ventilators, patient monitoring devices, and smart beds, experienced an extreme increase in sales. In fact, the company increased ventilator production by fivefold and are hiring temporary and permanent employees.&nbsp;</p>



<p>Other biomedical technology companies have experienced a market gain through the creation of precautionary medical equipment, such as Hologic.&nbsp;<a href="https://www.medtechdive.com/news/hologic-to-launch-2nd-coronavirus-test-amid-broader-sales-slide/577072/">Hologic</a>&nbsp;developed a SARS CoV-2 diagnostic test that is compatible with many hospital’s systems. The test produces results within three hours. Since the release of the test, the company has experienced their highest groth rate in eight years and has increased their production of the tests by 12-fold.&nbsp;</p>



<p>People have recognized this ability to succeed in the biomedical technology industry during this time, but some people have been dishonest when trying to find success. As such, the US FDA has seen an increase in fraudulent products. An explanation of the US FDA’s guidance for innovators and researchers can be found&nbsp;&nbsp;<a href="https://www.biospace.com/article/biopharma-update-on-the-novel-coronavirus-may-12/?s=93">here</a>. Therefore, although the biomedical technology field can help greatly during this difficult time, it is important to remember the regulatory steps required in the process.&nbsp;</p>



<p>For more information, please contact <a href="https://focalpointresearch.net/">Focal Point Research Inc</a>. We are leading North American <a href="https://focalpointresearch.net/services/regulatory-affairs/">Regulatory</a> and New Product Consultants for <a href="https://focalpointresearch.net/services/medical-devices/">Medical Devices</a>, <a href="https://focalpointresearch.net/services/natural-health-products/">Natural Health Products</a>, <a href="https://focalpointresearch.net/services/drugs/">OTC Drugs</a>, <a href="https://focalpointresearch.net/services/cosmetic-consultants/">Cosmetics</a>, and other <a href="https://focalpointresearch.net/services/consumer-products/">consumer products</a> regulated by <a href="https://focalpointresearch.net/services/health-canada-consultants/">Health Canada</a> and the <a href="https://focalpointresearch.net/services/fda-consulting/">U.S. FDA</a>.</p>
<p>The post <a href="https://focalpointresearch.net/medical-devices/covid-19-impacts-on-biomedical-technology-industry/">COVID-19 Impacts on Biomedical Technology Industry</a> appeared first on <a href="https://focalpointresearch.net">Focal Point</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">4851</post-id>	</item>
		<item>
		<title>Biotechnology: Production of Natural and Sustainable Ingredients</title>
		<link>https://focalpointresearch.net/canadian-regulatory/biotechnology-production-of-natural-and-sustainable-ingredients/</link>
		
		<dc:creator><![CDATA[Jenn Porter]]></dc:creator>
		<pubDate>Tue, 12 May 2020 21:27:40 +0000</pubDate>
				<category><![CDATA[Canadian Regulatory]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Research/Science/Technology]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Canadian Regulatory Consultants]]></category>
		<category><![CDATA[Focal Point Research]]></category>
		<category><![CDATA[Natural Ingredients]]></category>
		<category><![CDATA[Regulatory Affairs Consultants]]></category>
		<category><![CDATA[Scientific Regulatory & New Product Consultants]]></category>
		<category><![CDATA[Sustainable Ingredients]]></category>
		<guid isPermaLink="false">https://www.focalpointresearch.net/?p=4831</guid>

					<description><![CDATA[<p>The post <a href="https://focalpointresearch.net/canadian-regulatory/biotechnology-production-of-natural-and-sustainable-ingredients/">Biotechnology: Production of Natural and Sustainable Ingredients</a> appeared first on <a href="https://focalpointresearch.net">Focal Point</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<div class="et_pb_section et_pb_section_0 et_section_regular" >
				
				
				
				
				
				
				<div class="et_pb_row et_pb_row_0">
				<div class="et_pb_column et_pb_column_4_4 et_pb_column_0  et_pb_css_mix_blend_mode_passthrough et-last-child">
				
				
				
				
				<div class="et_pb_module et_pb_text et_pb_text_0  et_pb_text_align_left et_pb_bg_layout_light">
				
				
				
				
				<div class="et_pb_text_inner"><!-- divi:paragraph -->
<p>Consumers are more enticed to purchase a cosmetic or personal care product that displays the word ‘natural’ or ‘organic’, or a product that is known to contain ingredients from a sustainable source. This growing desire from consumers has led the cosmetic and personal care product industry to shift towards using ingredients from nature’s organisms as both active and inactive ingredients. However, just because an ingredient is naturally occurring, does not mean it is sustainable. For an ingredient to be <a href="https://www.sustainweb.org/ethicaleats/sustainablefood/" target="_blank" rel="noreferrer noopener">sustainable</a>, it must be obtained from a resource in a way that the ingredient will be available indefinitely. This led the cosmetic industry to begin using <a href="https://www.lexico.com/en/definition/biotechnology" target="_blank" rel="noreferrer noopener">biotechnology</a>, the use of a biological processes for industrial purposes and genetic manipulation of microorganisms. </p>
<!-- /divi:paragraph -->

<!-- divi:paragraph -->
<p><a href="https://explorebiotech.com/introduction-tools-and-applications-of-green-biotechnology/#Tools_and_Applications_of_Green_Biotechnology_in_Environmental_Biotechnology" target="_blank" rel="noreferrer noopener">Green biotechnology</a> is a method of genetically modifying plants to be more prosperous while maintaining a minimal environmental impact. Green biotechnology has been increasing in the agriculture industry in the twenty-first century, but recently the cosmetic industry has begun using these methods to grow their natural ingredients. For example, <a href="https://www.cosmeticsdesign-europe.com/Article/2020/04/28/Givaudan-tips-growth-for-ingredients-developed-with-green-biotech" target="_blank" rel="noreferrer noopener">Givaudan Active Beauty</a> has partnered with BIO-FD&amp;C to use green biotechnology to produce two new actives, k-phyto [SC] Camellia and k-phyto [PP] GHK. K-phyto [SC] Camellia is obtained from camellia phytoplacenta cells and is beneficial in scalp products as the active has been proven to aid in scalp moisture retention and reduces dry flakes and dandruff. K-phyto [PP] GHK combines botanicals and peptides and acts on sebum production mechanisms, making it perfect for products for oily skin. These actives are a prime example of making a more effective product while also appealing to consumers by using natural ingredients without disrupting the environment. </p>
<!-- /divi:paragraph -->

<!-- divi:paragraph -->
<p><a href="https://www.cosmeticsdesign-europe.com/Article/2020/04/28/Blue-biotechnology-for-cosmetics-holds-sustainable-raw-material-promise" target="_blank" rel="noreferrer noopener">Blue biotechnology</a> is a process of combining genetic engineering and cultivation techniques for mass production of marine organisms without impacting the ecosystem. Such organisms include bacteria, invertebrates, algae, and fungi. These marine sourced ingredients are better than terrestrially sourced ingredients as they are more active, have different properties, and different mechanisms of action. These ingredients allow products to contain photoprotection, moisturization, anti-ageing, and skin-whitening properties. By using blue biotechnology to source these materials, the marine ecosystem is protected from over-fishing and unnecessary ocean farming. There are seven million species living in the sea, and many more are unknown. The goal is to obtain samples of as many of these effective ingredients to begin farming them in a sustainable way.</p>
<!-- /divi:paragraph -->

<!-- divi:paragraph -->
<p>In order to further biotechnology’s applicability to the cosmetic and personal care product industry there are some challenges that need to be solved. For example, obtaining the original sample to begin the process requires a large amount of financial support. Additionally, as biotechnology grows and develops, government must also develop and adapt their financial support, legislations and guidelines to support the industry and to protect marine ecosystems. As biotechnology develops, its applications expands into other industries, such as natural health products and pharmaceuticals. It will be interesting to see where this and future biotechnologies take us.</p>
<!-- /divi:paragraph -->

<!-- divi:paragraph -->
<p>For more information, please contact&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/" target="_blank">Focal Point Research Inc.&nbsp;</a>We are leading North American&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/regulatory-affairs/" target="_blank">Regulatory</a>&nbsp;and New Product Consultants for&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/medical-devices/" target="_blank">Medical Devices</a>,&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/natural-health-products/" target="_blank">Natural Health Products</a>,&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/drugs/" target="_blank">OTC Drugs</a>,&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/cosmetic-consultants/" target="_blank">Cosmetics,</a>&nbsp;and other&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/consumer-products/" target="_blank">consumer products</a>&nbsp;regulated by&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/health-canada-consultants/" target="_blank">Health Canada&nbsp;</a>and the&nbsp;<a rel="noreferrer noopener" href="https://focalpointresearch.net/services/fda-consulting/" target="_blank">U.S. FDA</a></p>
<!-- /divi:paragraph -->

<!-- divi:paragraph -->
<p>Emily Campbell</p>
<!-- /divi:paragraph --></div>
			</div>
			</div>
				
				
				
				
			</div>
				
				
			</div>
<p>The post <a href="https://focalpointresearch.net/canadian-regulatory/biotechnology-production-of-natural-and-sustainable-ingredients/">Biotechnology: Production of Natural and Sustainable Ingredients</a> appeared first on <a href="https://focalpointresearch.net">Focal Point</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">4831</post-id>	</item>
	</channel>
</rss>
